focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Regulatory News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Open Orphan PLC

2 Jan 2020 11:44

RNS Number : 5666Y
Open Orphan PLC
02 January 2020
 

FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Greenwich Assets Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), sett/or and

beneficiaries must be named.

Peter Priestley

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Open Orphan plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of

offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

19/12/2019

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "NIA"

NO

If YES, specify which:

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

3,571,429

1.4

 

 

(2) Cash-settled derivatives:

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

 

TOTAL:

3,571,429

1.4

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

 

Details, including nature of the rights

concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1{c), copy table 3(a), (b}, (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit

 

 

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFO

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a

Iona/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

(i)  Writingsellingpurchasing or varying 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option

relates

Exercise price per unit

Type

e.g.

American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/

exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 (d) Other dealings (including subscribing for new securities)

 

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

the voting rights of any relevant securities under any option; orthe voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

 

NO

 

 

Date of disclosure:

19/12/2019

Contact name:

Apex Financial Services (Trustees) Limited

Telephone number*:

+44 (0) 1534 847000

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpane.lorq.uk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RETUUUARRSUARAR
Date   Source Headline
29th Jan 20204:43 pmRNSHolding(s) in Company
28th Jan 20207:00 amRNSCompulsory Acquisition of Remaining hVIVO Shares
27th Jan 20203:00 pmRNSHolding(s) in Company
23rd Jan 20207:00 amRNSUpdate on Placing
22nd Jan 20209:58 amRNSHolding(s) in Company
22nd Jan 20209:48 amRNSHolding(s) in Company
21st Jan 20202:07 pmRNSHolding(s) in Company
20th Jan 20204:28 pmRNSHolding(s) in Company
20th Jan 20208:00 amRNSEuronext Growth Dublin Notice
20th Jan 20207:59 amRNSEuronext Growth Dublin Cancellation Notice
20th Jan 20207:00 amRNSCompletion of Merger with hVIVO and Re-Admission
17th Jan 20207:00 amRNSOffer Wholly Unconditional
16th Jan 20202:00 pmRNSSchedule One Update
16th Jan 20202:00 pmRNSSchedule One Update - Open Orphan PLC
15th Jan 20205:30 pmRNSOpen Orphan
14th Jan 202011:12 amGNWForm 8.3 - Open Orphan plc
14th Jan 20207:00 amRNSSecond Closing of the Offer
13th Jan 20209:00 amRNSPrice Monitoring Extension
7th Jan 20202:12 pmRNSPublication and Posting of Rule 15 Proposals
6th Jan 20201:17 pmRNSResult of General Meeting
6th Jan 20208:00 amRNSSchedule One - Open Orphan plc
6th Jan 20208:00 amRNSSchedule One
6th Jan 20207:00 amRNSNew 3 Year Contract
2nd Jan 202011:55 amRNSForm 8.5 (EPT/NON-RI)
2nd Jan 202011:44 amRNSForm 8.3 - Open Orphan PLC
31st Dec 201911:00 amRNSForm 8.5 (EPT/NON-RI)
31st Dec 20197:00 amRNSOffer Update
30th Dec 201910:00 amRNSForm 8.5 (EPT/NON-RI)
23rd Dec 201910:00 amRNSForm 8.5 (EPT/RI) - Open Orphan plc
23rd Dec 20199:30 amRNSForm 8.5 (EPT/NON-RI)
20th Dec 20195:39 pmRNSForm 8.3 - Open Orphan Plc
19th Dec 20194:39 pmRNSForm 8.3 - Open Orphan plc
19th Dec 20191:36 pmRNSForm 8.3 - Open Orphan plc
19th Dec 201911:55 amRNSForm 8.5 (EPT/NON-RI)
18th Dec 201912:05 pmRNSForm 8.5 (EPT/NON-RI)
18th Dec 20197:00 amRNSNew Contract with SFA Therapeutics
17th Dec 20194:38 pmRNSForm 8.3 - Open Orphan Plc
17th Dec 20194:36 pmRNSForm 8 (OPD)
17th Dec 20192:06 pmRNSForm 8.3 - Open Orphan PLC
17th Dec 20192:06 pmRNSForm 8.3 - Open Orphan PLC
17th Dec 20192:04 pmRNSForm 8.3 - Open Orphan PLC
17th Dec 20192:04 pmRNSForm 8.3 - Open Orphan PLC
17th Dec 201911:55 amRNSForm 8.5 (EPT/NON-RI)
17th Dec 201910:19 amRNSForm 8 (OPD)
17th Dec 201910:19 amRNSForm 8 (OPD) (hVIVO plc)
16th Dec 20192:02 pmRNSForm 8 (OPD) Open Orphan plc
16th Dec 201911:55 amRNSForm 8.5 (EPT/NON-RI)
16th Dec 201910:26 amRNSForm 8.5 (EPT/RI) - Open Orphan plc
13th Dec 201911:44 amRNSForm 8.3 - Open Orphan PLC
13th Dec 20197:00 amRNSForm 8.3 - Open Orphan plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.